TY  - JOUR 
T1  - Editorial Comment: Abiraterone in “High-” and “Low-risk” Metastatic Hormone-sensitive Prostate Cancer
JO  - International braz j urol
A1  - Lott, Felipe
SN  - 1677-5538
UL  - 10.1590/S1677-5538.IBJU.2021.01.08
VL  - 47 
Y1  - 2021
PB  - Brasil 
ER  -